{
  "_id": "c7204b2dd5ef767a70ea78cb163bb5b96e92bdf8ae557f13a0435e3db516f430",
  "feed": "market-watch",
  "title": "China COVID cases could double next month, as Merck antiviral gets approval",
  "text": "<p>The U.K. health firm Airfinity estimates that daily Chinese COVID-19 infections will peak in the middle of January, at 3.7 million, from a current 1.8 million. Another wave will then occur in March, where cases will reach 4.2 million per day, Airfinity estimates. The Airfinity numbers are far higher than official estimates.</p><p>Deaths will total 1.7 million by the end of April 2023, from 100,000 now, Airfinity said.</p><p>The Airfinity model is based on data from China's regional provinces along with case growth in other former zero-COVID countries such as Hong Kong and Japan.</p><p>China COVID cases could double next month, as Merck antiviral gets approval</p>",
  "published": "2022-12-30T14:12:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "nexusId": "10042334",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 46,
          "end": 51
        },
        {
          "start": 620,
          "end": 625
        }
      ]
    }
  ]
}